Last update 29 Aug 2025

Viva Star Biosciences (Suzhou) Co., Ltd.

Subsidiary Company|2021|Jiangsu Sheng, China

Overview

Tags

Other Diseases
Nervous System Diseases
Immune System Diseases
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases3
Immune System Diseases2
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug3
Chemical drugs1
Top 5 TargetCount
LPAR1(Lysophosphatidic acid receptor Edg-2)1
NLRP3(NACHT, LRR and PYD domains-containing protein 3)1
GPCR(G-protein coupled receptor)1

Related

4
Drugs associated with Viva Star Biosciences (Suzhou) Co., Ltd.
VS-2218
Target-
Mechanism-
Active Org.
Viva Star Biosciences (Suzhou) Co., Ltd.
Originator Org.
Viva Star Biosciences (Suzhou) Co., Ltd.
Active Indication
Pulmonary Fibrosis [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
NLRP3 inhibitors (Viva Star Biosciences)
Target
NLRP3
Mechanism
NLRP3 inhibitors
Active Org.
Viva Star Biosciences (Suzhou) Co., Ltd. [+1]
Originator Org.
Viva Star Biosciences Limited
Active Indication
Fibrosis [+5]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
LPAR1 Antagonists (Viva Star)
Target
LPAR1
Mechanism
LPAR1 antagonists
Active Org.
Viva Star Biosciences (Suzhou) Co., Ltd.
Originator Org.
Viva Star Biosciences (Suzhou) Co., Ltd.
Active Indication
Fibrosis [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Viva Star Biosciences (Suzhou) Co., Ltd.
CTR20252886
/ Not yet recruitingPhase 1
一项在中国健康成年受试者中评估单/多次口服VS-2218 固体分散体片的安全性、耐受性、药代动力学特征以及食物影响的Ⅰ期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and food effects of single/multiple oral administration of VS-2218 solid dispersion tablets in healthy Chinese adult subjects
100 Clinical Results associated with Viva Star Biosciences (Suzhou) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Viva Star Biosciences (Suzhou) Co., Ltd.
Login to view more data
100 Deals associated with Viva Star Biosciences (Suzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Viva Star Biosciences (Suzhou) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
4
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free